Brief: Progenity Strengthens Intellectual Property For Single-Molecule Detection Technology With Additional Patent
25/01/2022 21:34
Jan 25 (Reuters) - Progenity Inc PROG.O :
* PROGENITY STRENGTHENS INTELLECTUAL PROPERTY FOR
SINGLE-MOLECULE
DETECTION TECHNOLOGY WITH ADDITIONAL PATENT
Source text for Eikon: ID:nGNXTCxGr
Further company coverage: PROG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules